◀ Back to APOB

APOB — CSRP1

Text-mined interactions from Literome

van Tits et al., Arterioscler Thromb Vasc Biol 2005 : In the presence of 2 to 10 mg/L CRP , binding of 125I labeled oxidized LDL to undifferentiated U937 cells increased 50 % to 100 % ... These findings suggest that : ( 1 ) CRP and annexin A5 at physiological concentrations bind to distinct sites of negatively charged phospholipids present in oxidized LDL ; ( 2 ) CRP enhances binding of oxidized LDL to monocytic/macrophage-like cells via Fcgamma receptors ; and ( 3 ) annexin A5 does not antagonize the CRP induced enhanced binding of oxidized LDL to U937 cells
Kobayashi et al., Ther Apher Dial 2006 (Arterial Occlusive Diseases...) : LDL-apheresis reduces P-Selectin, CRP and fibrinogen -- possible important implications for improving atherosclerosis
Singh et al., Clin Chim Acta 2009 : In the presence of the small-molecule compound phosphoethanolamine ( PEt ), at 37 degrees C, the binding of mCRP to E-LDL was enhanced < 2-fold, while the binding of CRP to E-LDL was enhanced > 10-fold
Mookerjea et al., Arterioscler Thromb 1994 : In contrast, the degradation of 125I-acetyl-LDL by macrophages was not affected by rat CRP, although acetylated LDL inhibited the rat CRP stimulated degradation of 125I-LDL ... Our results suggested that the increased degradation of 125I-LDL was caused by the charge modification of 125I-LDL by rat CRP , due to a fluid-phase complex formation between 125I-LDL and rat CRP, and that the degradation involved the scavenger receptor present on the macrophages